- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04199676
Immediate Postpartum Glucose Tolerance Testing
Immediate Postpartum Glucose Tolerance Testing Among Gestational Diabetics: A Comparison to the Gold Standard
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Gestational diabetes affects approximately 5-10% of pregnancies and its prevalence continues to increase as rates of obesity and metabolic disease increase in reproductive age women. Women diagnosed with gestational diabetes carry an increased risk of developing type 2 diabetes later in life, even if their glucose tolerance initially normalizes following delivery.
The gold standard assessment of glucose tolerance postpartum is a two hour glucose tolerance test (GTT) that is completed between six and twelve weeks' postpartum. Unfortunately, the compliance rate with this test is low, ranging from 30 - 50% by most reports. As a result, a large number of women with glucose intolerance are missed due to noncompliance with postpartum testing, thereby forfeiting the opportunity for diagnosis, treatment and prevention of longterm health consequences. The postpartum hospital stay provides a unique opportunity to increase compliance with glucose tolerance testing due to an increased rate of patient capture. However, it is unknown if administration of a glucose tolerance test in the immediate postpartum period would adequately identify women with persistent glucose intolerance.
The current study aims to provide data towards the accuracy of an immediate postpartum GTT in a population of women with gestational diabetes and provide follow-up data on women with abnormal testing.
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Contact
- Name: Kenneth Chan, MD
- Phone Number: (562) 997-8510
- Email: kenneth_chan@mednax.com
Study Contact Backup
- Name: Ashten Waks, MD
- Phone Number: (949) 702-0704
- Email: awaks@hs.uci.edu
Study Locations
-
-
California
-
Long Beach, California, United States, 90806
- Recruiting
- Long Beach Memorial Medical Center/Miller Children's and Women's Hospital
-
Contact:
- Kenneth Chan, MD
- Email: KChan@memorialcare.org
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Pregnant or recently postpartum (postpartum day 0 or 1)
- ≥ 18 years of age
- Gestational age ≥34 weeks
- A1 or A2 gestational diabetes
Exclusion Criteria:
- Medical exclusion from completing glucose tolerance testing
- Steroid administration within 10 days prior to enrollment
- Chronic steroid use
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Intervention
75g glucose tolerance test to be administered during postpartum hospitalization
|
Oral administration of a 75g glucose tolerance test during the postpartum hospitalization
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Accuracy of immediate glucose tolerance testing
Time Frame: 6-12 weeks postpartum
|
Diagnostic accuracy between immediate postpartum glucose tolerance testing and gold standard testing
|
6-12 weeks postpartum
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Compliance with standard glucose tolerance testing
Time Frame: 12 weeks postpartum
|
Percentage of the cohort that comply with glucose tolerance testing at their postpartum visit
|
12 weeks postpartum
|
Transition to primary care
Time Frame: 12 weeks postpartum
|
Percentage of cohort that are appropriately referred to ongoing primary care
|
12 weeks postpartum
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Kenneth Chan, MD, Magella Medical Group
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- MHS 925-19
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Gestational Diabetes
-
IRCCS Burlo GarofoloCompletedGestational Diabetes | Gestational Diabetes Mellitus | Pregnancy-Induced Diabetes | Diabetes Mellitus, Gestational | Diabetes, Pregnancy InducedIsrael, Italy, Netherlands, Slovenia, Sri Lanka
-
UPECLIN HC FM Botucatu UnespCompletedGestational Diabetes Mellitus | Pregestational Diabetes Mellitus | Mild Gestational HyperglycemiaBrazil
-
Assistance Publique - Hôpitaux de ParisCompleted
-
University of Texas Southwestern Medical CenterCompletedMild Gestational DiabetesUnited States
-
Royal College of Surgeons, IrelandHealth Research Board, IrelandUnknownPre-Gestational Diabetes
-
University of Colorado, DenverKaiser PermanenteCompletedGestational Diabetes MellitusUnited States
-
Intermountain Health Care, Inc.Withdrawn
-
McGill University Health Centre/Research Institute...The Lawson FoundationCompletedGestational Diabetes Mellitus With Baby DeliveredCanada
-
Woman'sBaton Rouge Area FoundationCompletedGestational Diabetes MellitusUnited States
-
Brigham and Women's HospitalUniversity of Colorado, DenverCompletedGestational Diabetes MellitusUnited States
Clinical Trials on Glucose tolerance test
-
University Hospital Schleswig-HolsteinUniversity of KielRecruitingParkinson Disease | Nutritional and Metabolic Diseases | Sugar IntakeGermany
-
Universität des SaarlandesCompleted
-
US Department of Veterans AffairsEmory UniversityCompletedType 2 Diabetes Mellitus | Prediabetic StateUnited States
-
NYU Langone HealthCompletedGlucose Metabolism Disorders | Diabetes Mellitus | Prediabetic State | Diabetes, GestationalUnited States
-
Imperial College LondonCompleted
-
University College DublinCompletedHealthy SubjectsIreland
-
University of NebraskaCompletedDiabetes | TransplantUnited States
-
Zhujiang HospitalRecruitingDiabetes Mellitus | Prediabetes | Gestational Diabetes Mellitus | ProteomicsChina
-
University of NottinghamCompletedGastrointestinal DysfunctionUnited Kingdom
-
Seoul National University HospitalCompletedDiabete Mellitus | Pancreatectomy; Hyperglycemia